We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

EKF Highlights Growing Product Portfolio at AACC 2014 Meeting

By LabMedica International staff writers
Posted on 04 Aug 2014
Print article
EKF Diagnostics (Cardiff, UK), a global diagnostics company, is highlighting the expanding product portfolio of its subsidiary Stanbio Laboratory (Boerne, TX, USA) at AACC 2014. EKF Diagnostics has distributors in more than 70 locations around the globe, multinational research and manufacturing facilities, and teams of experienced analysts and engineers in Germany, Ireland, USA, and the UK.

In addition to demonstrating the success of current products, including Stanbio’s ß-hemoglobin (HB) assay technology and EKF Molecular’s Pointman technology, new products will be introduced at AACC. These latest introductions result from EKF’s recent acquisition of Separation Technology Inc. (STI) and DiaSpect Medical.

The diagnostic effectiveness of Stanbio’s enzymatic Beta-Hydroxybutyrate (ß-HB) LiquiColor assay is driving its acceptance in hospital laboratories across the USA as the new standard of care in ketosis testing. More than 850 (20%) of US hospitals are now using the assay for accurate, specific, and quantitative testing of this main ketone produced during ketosis. Consequently, physicians can make better informed clinical decisions. This is changing the way hospitals manage patients displaying symptoms of ketoacidosis.

The liquid-stable LiquiColor ß-HB reagent can be used on open channel chemistry analyzers from twenty different manufacturers. A point-of-care (POC) option is also available in the form of the STAT-Site M ß-HB strip-based testing system.

Since its introduction last year, PointMan DNA enrichment technology has now been shown to be sensitive enough to enable the use of a blood sample to assess the mutation status of a cancer patient. Recent studies have demonstrated that the sensitivity of the technology is far greater than existing polymerase chain reaction (PCR) technology. PointMan can detect 1 mutant gene in 10,000 normal gene copies, whereas competing technologies can only detect 1 in 100. This maximizes the use of smaller biopsy samples and also allows the multiplexing of mutations in a single test rather than many individual tests.

To be previewed at AACC, the palm-sized DiaSpect is a fast HB measurement system giving laboratory quality performance for anemia screening in any environment. Delivering results in 1-2 seconds, the analyzer is CE marked and has been submitted to the US Food and Drug Administration (FDA; Silver Spring, MD, USA) for approval.

The PlasmaPrep-12 centrifuge is ideal for use in both the hospital and laboratory. It is designed for STAT serum/plasma separation and is suitable for coagulation studies. Enabling fast blood separation and easy to use, it is controlled by a microprocessor with four preprogrammed spin times. These include the Platelet Poor Plasma mode providing serum or plasma separations in three minutes and the Platelet Rich Plasma mode providing platelet rich plasma in just 30 seconds.

Julian Baines, CEO of EKF, commented, "EKF now offers a comprehensive and cost-effective product range, as well as meaningfully participating in personalized medicine; an area which is quickly becoming key within the IVD industry.”

Related Links:

EKF Diagnostics
Stanbio Laboratory


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.